Anthrax Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
Condition:   Infections, BacterialInterventions:   Biological: AVA;   Biological: Raxibacumab;   Drug: DiphenhydramineSponsor:   GlaxoSmithKlineRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2015 Category: Research Source Type: clinical trials

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
Condition:   Infections, BacterialInterventions:   Biological: AVA;   Biological: Raxibacumab;   Drug: DiphenhydramineSponsor:   GlaxoSmithKlineActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2015 Category: Research Source Type: clinical trials

A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine in Healthy Adults
Conditions:   Safety;   Tolerability;   ReactogenicityIntervention:   Biological: PA83-FhCMBSponsor:   Fraunhofer, Center for Molecular BiotechnologyRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2014 Category: Research Source Type: clinical trials